Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹64.2 Cr NA -12.1% -51.9% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,226.8 Cr 3% -5.2% -6% Stock Analytics
KIRI INDUSTRIES ₹3,001.7 Cr 9% -12.1% -22.6% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,581.5 Cr 2.2% -4.1% -35.3% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,096.4 Cr -3.1% -5.3% 27.7% Stock Analytics
BODAL CHEMICALS ₹646.3 Cr 8.5% -2% -17.5% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC NA

-12.1%

-51.9%

SENSEX

1.3%

-2.5%

8.5%


You may also like the below Video Courses